Infiltration of CD40-positive tumor-associated macrophages indicates a favorable prognosis in colorectal cancer patients

Hepato-Gastroenterology

Volumn 60, Issue 122, 2013, Pages 83-88

  Kinouchi, Makoto ^a,b   Miura, Koh ^b   Mizoi, Takayuki ^b   Ishida, Kazuyuki ^c   Fujibuchi, Wataru ^d   Sasaki, Hiroyuki ^b   Ohnuma, Shinobu ^b   Saito, Kazuya ^e   Katayose, Yu ^b   Naitoh, Takeshi ^b   Motoi, Fuyuhiko ^b   Shiiba, Ken Ichi ^a,b   Egawa, Shinichi ^b   Shibata, Chikashi ^b   Unno, Michiaki ^b  

^a Miyagi Cancer Center   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c TOHOKU UNIVERSITY HOSPITAL   (Japan)

^d NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^e Sendai Postal Services Agency Hospital   (Japan)

Author keywords

CD40; Colon cancer; Prognostic indicator; Tumor associated macrophage

Indexed keywords

B7 ANTIGEN; CD14 ANTIGEN; CD40 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; HLA DR ANTIGEN; T6 ANTIGEN;

AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CANCER TISSUE; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNITY;

AGED; ANTIGENS, CD40; COLORECTAL NEOPLASMS; FEMALE; FLOW CYTOMETRY; HUMANS; MACROPHAGES; MALE; PROGNOSIS;

EID: 84877698867     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge12372     Document Type: Article

References (24)

1. De Visser KE, Eichten A, Coussens LM: Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 2006; 6:24-37. (Pubitemid 43053650)
2. Hume DA: Macrophages as APC and the dendritic cell myth. J Immunol 2008; 181:5829-5835.
3. Gooden MJ, de Bock GH, Letters N, et al.: The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis. Br J Cancer 2011; 105:93-103.
4. Iwamoto M, Shinohara H, Miyamoto A, et al.: Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas. Int J Cancer 2003; 104:92-97. (Pubitemid 36184151)
5. Du C, Wang Y: The immunoregulatory mechanisms of carcinoma for its survival and development. J Exp Clin Cancer Res 2011; 30:12.
6. Chen L: Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol 2004; 4:336-347.
7. Holness CL, Simmons DL: Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Blood 1993; 81:1607-1613. (Pubitemid 23083842)
8. Kielian TL, Blecha F: CD14 and other recognition molecules for lipopolysaccharide: a review. Immunopharmacology 1995; 29:187-205.
9. Kinouchi M, Miura K, Mizoi T, et al.: Infiltration of CD14-positive macrophages at the invasive front indicates a favorable prognosis in colorectal cancer patients with lymph node metastasis. Hepato-gastroenterol 2011; 58:352-358.
10. Kalinski P, Schuitemaker JH, Hilkens CM, et al.: Prostaglandin E2 induces the final maturation of IL-12-deficient CD1a+CD83+ dendritic cells: the levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation. J Immunol 1998; 161:2804-2809. (Pubitemid 28425700)
11. Lewis CE, Pollard JW: Distinct role of macrophages in different tumor microenvironments. Cancer Res 2006; 66:605-612. (Pubitemid 43165918)
12. Oosterling SJ, van der Bij GJ, Meijer GA, et al.: Macrophages direct tumour histology and clinical outcome in a colon cancer model. J Pathol 2005; 207:147-155. (Pubitemid 41404145)
13. Sickert D, Aust DE, Langer S, et al.: Characterization of macrophage subpopulations and microvessel density in carcinomas of the gastrointestinal tract. Anticancer Res 2007; 27:1693-1700. (Pubitemid 46807260)
14. Japanese Society for Cancer of the Colon and Rectum: General rules for clinical and pathological studies on cancer of the colon, rectum and anus, 6th ed. Tokyo, Japan, Kanehara Publishers; 1998.
15. Chen JJ, Lin YC, Yao PL, et al.: Tumor-associated macrophages: The double-edged sword in cancer progression. J Clin Oncol 2005; 23:953-964. (Pubitemid 46202315)
16. Forssell J, Oberg A, Henriksson ML, et al.: High macrophage infiltration along the tumor front correlates with improved survival in colon cancer. Clin Cancer Res 2007; 13:1472-1479. (Pubitemid 46450437)
17. Brode S, Macary PA: Cross-presentation: dendritic cells and macrophages bite off more than they can chew! Immunology 2004; 112:345-351. (Pubitemid 38859511)
18. O'Sullivan B, Thomas R: CD40 and dendritic cell function. Crit Rev Immunol 2003; 23:83-107. (Pubitemid 36875475)
19. Harris NL, Ronchese F: The role of B7 co-stimulation in T-cell immunity. Immunol Cell Biol 1999; 77:304-311.
20. Frucht DM, Fukao T, Bogdan C, et al.: IFN-gamma production by antigen-presenting cells: mechanisms emerge. Trends Immunol 2001; 22:556-560. (Pubitemid 33016402)
21. Mellman I, Coukos G, Dranoff G: Cancer immunotherapy comes of age. Nature 2011; 480:480-489.
22. Topalian SL, Weiner GJ, Pardoll DM: Cancer immunotherapy comes of age. J Clin Oncol 2011; 29:4828-4836.
23. Engstrom PF, Arnoletti JP, Benson AB 3rd, et al.: NCCN clinical practice guidelines in oncology: colon cancer. J Natl Compr Canc Netw 2009; 7:778-831.
24. Lewis TS, McCormick RS, Emmerton K, et al.: Distinct apoptotic signaling characteristics of the anti-CD40 monoclonal antibody dacetuzumab and rituximab produce enhanced antitumor activity in non-Hodgkin lymphoma. Clin Cancer Res 2011; 17:4672-4681.